Related Experiment Videos
Endomyocardial biopsy in patients with systemic lupus erythematosus
M J Fairfax1, T G Osborn, G A Williams
1Department of Internal Medicine, St. Louis University School of Medicine, MO 63104.
Insights
Systemic lupus erythematosus (SLE) can cause silent myocarditis. Endomyocardial biopsies in SLE patients helped diagnose cardiac inflammation and guide immunosuppressive therapy.
Area of Science:
- Cardiology
- Rheumatology
- Pathology
Background:
- Systemic lupus erythematosus (SLE) is associated with diverse cardiovascular complications.
- Myocarditis, or heart muscle inflammation, is a frequent autopsy finding in SLE patients (over 50%).
- Clinical detection of myocarditis in SLE can be challenging due to its often asymptomatic nature.
Observation:
- Percutaneous endomyocardial biopsy was utilized in four SLE patients.
- This diagnostic procedure provided crucial information about the heart's condition.
Findings:
- The biopsy was instrumental in diagnosing inflammatory myocarditis.
- It accurately determined the extent of myocardial inflammation.
- Biopsy results directly influenced treatment strategies.
Implications:
- Endomyocardial biopsy is a valuable tool for diagnosing subclinical myocarditis in SLE.
- Accurate diagnosis and assessment of myocarditis severity can optimize immunosuppressive therapy.
- Improved management of cardiac manifestations in SLE may lead to better patient outcomes.
Abstract:
Systemic lupus erythematosus (SLE) has numerous cardiovascular manifestations. Myocarditis is present in more than 50% of patients with SLE at autopsy, but it may be silent clinically during life. Percutaneous endomyocardial biopsy performed in 4 patients with SLE was found helpful in establishing the diagnosis and in determining the extent of the inflammatory myocarditis. The findings aided the regulation of therapy, particularly the administration of immunosuppressive drugs.